AFT Pharmaceuticals (ASX:AFP) has confirmed that its financial results for the six months ended 30 September 2026 will be released prior to the NZX and ASX market open on Thursday, 26 November 2026, with an investor and analyst webinar to follow at 10:30 am New Zealand Daylight Time.
Key Points
- Half-year results for the six months ended 30 September 2026 to be released on 26 November 2026, before NZX and ASX open
- An investor and analyst webinar will be hosted at 10:30 am NZDT on the same day
- Presentation materials will be made available on the NZX and ASX websites
- The filing was released on 19 November 2026 and authorised by Chief Financial Officer Stuart Houliston
Half-Year Results Release Date and Timing
AFT Pharmaceuticals disclosed that its results for the six months ended 30 September 2026 will be published ahead of the opening of both the NZX and ASX on Thursday, 26 November 2026. The company, which is dual-listed on the NZX and ASX under the tickers AFT and AFP respectively, confirmed the release date in a filing dated 19 November 2026. The filing was released for and on behalf of AFT Pharmaceuticals Limited by Stuart Houliston, the company's Chief Financial Officer.
Investor and Analyst Webinar Details
AFT Pharmaceuticals stated that a webinar for investors and analysts will be hosted at 10:30 am New Zealand Daylight Time on 26 November 2026, coinciding with the release of the half-year results. The company noted that presentation materials will be available on the company's investor website, the NZX website, and the ASX website. Participants wishing to attend the webinar were directed to pre-register, with webinar access details to be provided upon completion of registration.
Reporting Period Covered by the Results
The upcoming results disclosure covers the first half of AFT Pharmaceuticals' financial year 2027, specifically the six-month period ended 30 September 2026. The company did not disclose any financial figures, operational updates, or guidance in this filing. The notice was limited to confirming the scheduled release date, the timing and format of the associated investor briefing, and the channels through which presentation materials will be made available to market participants.



Please wait processing your request...